MetaCap

Abbott Laboratories (ABT) vs Vertex Pharmaceuticals (VRTX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Vertex Pharmaceuticals (VRTX) has outperformed Abbott Laboratories (ABT) over the past year, gaining 20.7% versus a loss of 19.6%. Over five years, VRTX leads with a +180.5% price change compared with -18.2% for ABT. Abbott Laboratories is the larger company by market cap ($178.39 billion vs $130.58 billion), about 1.4 times the size, while Vertex Pharmaceuticals is growing revenue faster (+8.9% vs +5.7%).

On valuation, Abbott Laboratories trades at a lower forward P/E (17.3x vs 25.9x for Vertex Pharmaceuticals). Abbott Laboratories pays a dividend yielding 2.45%, while Vertex Pharmaceuticals does not currently pay one. Vertex Pharmaceuticals converts more of its revenue into profit, with a net margin of 32.9% versus 14.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ABT-19.60%VRTX+20.68%
+34%-2%-39%
Nov 21, 20251 yearNov 20, 2026
ABT-18.80%VRTX+181.62%
+218%+86%-45%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ABT versus VRTX key metrics
MetricABTVRTX
Share price$103.00$515.02
Market cap$178.39B$130.58B
1-day change-0.84%-1.08%
YTD return-17.79%+13.60%
1-year return-19.60%+20.68%
5-year return-18.18%+180.53%
P/E ratio (TTM)38.4333.14
Forward P/E17.3525.86
EPS (TTM)$2.68$15.54
Dividend yield2.45%0.00%
Annual dividend$2.52$0.00
Revenue (latest FY)$44.33B$12.00B
Revenue growth (YoY)+5.67%+8.90%
Net income (latest FY)$6.52B$3.95B
Gross margin56.42%86.24%
Operating margin18.17%34.77%
Net margin14.72%32.94%
52-week high$129.85$568.67
52-week low$81.97$412.27
Distance from 52-week high-20.68%-9.43%
Analyst consensusbuybuy
Avg. price target upside+15.45%+15.60%
Average volume8.89M1.25M
Shares outstanding1.73B253.54M
Employees122,0006,400
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • VRTX has outperformed ABT by 40.3 percentage points over the past year.
  • Abbott Laboratories offers a meaningfully higher dividend yield (2.45% vs 0.00%).
  • Vertex Pharmaceuticals is more profitable, keeping 32.9 cents of every revenue dollar as net income versus 14.7 cents for Abbott Laboratories.

About Abbott Laboratories

ABT stock →

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

Health Care · Biotechnology: Pharmaceutical Preparations · 122,000 employees

About Vertex Pharmaceuticals

VRTX stock →

Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain.

Health Care · Biotechnology: Pharmaceutical Preparations · 6,400 employees

ABT vs VRTX FAQ

Which is bigger, Abbott Laboratories or Vertex Pharmaceuticals?

Abbott Laboratories (ABT) is larger, with a market capitalization of $178.39B compared with $130.58B for Vertex Pharmaceuticals (VRTX).

Which stock has performed better over the past year, ABT or VRTX?

VRTX returned +20.68% over the past 12 months, compared with -19.60% for ABT (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, ABT or VRTX?

VRTX has the lower trailing P/E at 33.1, versus 38.4 for ABT. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Abbott Laboratories or Vertex Pharmaceuticals?

Abbott Laboratories pays a dividend yielding 2.45%, while Vertex Pharmaceuticals does not currently pay a regular dividend.

Are Abbott Laboratories and Vertex Pharmaceuticals in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons